Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-07

Clinical Trial Update: Human Milk Oligosaccharides (HMOs) for Irritable Bowel Syndrome (IBS) [NA]

View source ↗

Summary

A clinical trial evaluating human milk oligosaccharides for irritable bowel syndrome was terminated; no results are provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Human milk oligosaccharides

Snippet

Sponsor: dsm-firmenich Switzerland AG | Conditions: Irritable Bowel Syndrome, IBS - Irritable Bowel Syndrome | NA | Status: TERMINATED